4BASEBIO UK SOCIETAS (4BB.L)
4basebio plc engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio plc in July 2021. 4basebio plc was founded in 2008 and is based in Cambridge, the United Kingdom.
Company Info
| ISIN | GB00BMCLYF79 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | £137.02M |
|---|---|
| EPS | -£0.51 |
| Revenue (TTM) | £354.00K |
| Gross Profit (TTM) | £269.00K |
| EBITDA (TTM) | -£6.36M |
| Year Range | £492.00 - £1,120.00 |
| Target Price | £1,200.00 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in 4BASEBIO UK SOCIETAS, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
4BASEBIO UK SOCIETAS had a return of 58.09% year-to-date (YTD) and 67.97% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 58.09% | 5.21% |
| 1 month | 11.98% | -4.30% |
| 6 months | 108.74% | 18.42% |
| 1 year | 67.97% | 21.82% |
| 5 years (annualized) | N/A | 11.27% |
| 10 years (annualized) | N/A | 10.33% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -1.47% | 21.64% | 17.79% | 11.46% | ||||||||
| 2023 | -7.62% | 9.71% | 20.35% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of 4BB.L is 92, placing it in the top 8% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
4BASEBIO UK SOCIETAS(4BB.L)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for 4BASEBIO UK SOCIETAS (4BB.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the 4BASEBIO UK SOCIETAS. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the 4BASEBIO UK SOCIETAS was 47.71%, occurring on Jul 13, 2022. Recovery took 410 trading sessions.
The current 4BASEBIO UK SOCIETAS drawdown is 4.02%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -47.71% | Sep 30, 2021 | 196 | Jul 13, 2022 | 410 | Feb 27, 2024 | 606 |
| -31.11% | Feb 22, 2021 | 15 | Mar 12, 2021 | 71 | Jun 25, 2021 | 86 |
| -9.72% | Sep 2, 2021 | 10 | Sep 15, 2021 | 10 | Sep 29, 2021 | 20 |
| -9.44% | Aug 10, 2021 | 6 | Aug 17, 2021 | 9 | Aug 31, 2021 | 15 |
| -7% | Mar 15, 2024 | 13 | Apr 4, 2024 | 6 | Apr 12, 2024 | 19 |
Volatility
Volatility Chart
The current 4BASEBIO UK SOCIETAS volatility is 11.28%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |